FP
Frederic Pla
Chief Operating Officer

Frederic Pla insider trades: Akoya Biosciences (AKYA) stock buys and sales

Chief Operating Officer, Akoya Biosciences Last trade Sep 7, 2023 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2018
2
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Frederic reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 7, 2023AKYA↑ Buy$92K
Aug 19, 2019GHDX↓ Sell$94K
Mar 19, 2019GHDX↓ Sell$428K
Feb 21, 2019GHDX↓ Sell$68K
Feb 19, 2019GHDX↓ Sell$807K
Nov 7, 2018GHDX↓ Sell$3.7M
Oct 8, 2018GHDX↓ Sell$98K
Sep 10, 2018GHDX↓ Sell$94K
Aug 9, 2018GHDX↓ Sell$308K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Frederic Pla's insider trades

Frederic Pla is Chief Operating Officer at Akoya Biosciences (AKYA). Since Aug 9, 2018, Frederic has reported 1 open-market purchase worth $92K and 8 sales worth $5.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (8 filings), shares withheld for taxes (7 filings), option exercises (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AKYA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.